Literature DB >> 2412341

The significance of giant cells in human testicular seminomas. A clinico-pathological study.

A R von Hochstetter, C Sigg, P Saremaslani, C Hedinger.   

Abstract

In order to study the nature and significance of various giant cells encountered in seminomatous tumors of the testis, we reviewed the morphology of 243 consecutive pure seminomas and 107 combined (mixed) tumors, as well as the long term clinical follow-up in 26 patients. Giant cells were grouped into histiocytic or neoplastic ones and the latter subtyped according to morphologic and immunocytochemical characteristics. Neoplastic giant cells were found in 34.6% of all pure seminomas and in 11.2% of all combined tumors, i.e. twice as often as histiocytic giant cells in either tumor group. The various types of neoplastic giant cells were found alone or in combinations with other types. Giant cells capable of elaborating B-HCG were seen in 19.3% of all pure seminomas and in 9.3% of seminomatous components of combined tumors. These incidences argue strongly against a trophoblastic element infiltrating a seminoma from a concomitant occult choriocarcinomatous focus. Large mononuclear giant cells, seen in spermatocytic seminomas, were observed in 15.6% of all pure seminomas, particularly in combination with B-HCG producing giant cells. Another type, characterized by marginated nuclei and eosinophilic cytoplasm were invariably part of a mononuclear cell population of similar features and encountered focally in 9.1% of all pure seminomas. Clinical follow-up, particularly in cases with B-HCG positive giant cells, revealed that treatment as for conventional seminomas at an early stage at least is followed by an excellent course.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2412341     DOI: 10.1007/bf00710656

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  15 in total

1.  The significance of positive chorionic gonadotropins in apparently pure seminoma of the testis.

Authors:  P Mauch; R Weichselbaum; L Botnick
Journal:  Int J Radiat Oncol Biol Phys       Date:  1979-06       Impact factor: 7.038

2.  The unlabeled antibody enzyme method of immunohistochemistry: preparation and properties of soluble antigen-antibody complex (horseradish peroxidase-antihorseradish peroxidase) and its use in identification of spirochetes.

Authors:  L A Sternberger; P H Hardy; J J Cuculis; H G Meyer
Journal:  J Histochem Cytochem       Date:  1970-05       Impact factor: 2.479

3.  Prognostic and therapeutic implications of urinary gonadotropin levels in the management of testicular neoplasia.

Authors:  J M Wilson; D M Woodhead
Journal:  J Urol       Date:  1972-11       Impact factor: 7.450

4.  Proceedings: Radiation therapy in malignant testis tumors. II: Carcinoma.

Authors:  J G Maier; M H Sulak
Journal:  Cancer       Date:  1973-11       Impact factor: 6.860

5.  The differential diagnosis of testicular germ cell tumors in theory and practice. A critical analysis of two major systems of classifiction and review of 389 cases.

Authors:  A R von Hochstetter; C E Hedinger
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1982-08

6.  "Seminoma with trophocarcinoma". A clinical variant of seminoma.

Authors:  M Friedman; A W Pearlman
Journal:  Cancer       Date:  1970-07       Impact factor: 6.860

7.  Seminoma with syncytiotrophoblastic giant cells. A special form of seminoma.

Authors:  C Hedinger; A R von Hochstetter; B Egloff
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1979-07-27

8.  The frequency and morphology of "giant spermatogonia" in the human testis.

Authors:  C Sigg; C Hedinger
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1983

9.  Serum alpha-fetoprotein and human chorionic gonadotropin in patients with seminoma.

Authors:  P H Lange; L E Nochomovitz; J Rosai; E E Fraley; B J Kennedy; G Bosl; J Brisbane; W J Catalona; J S Cochran; R H Comisarow; K B Cummings; J B deKernion; L H Einhorn; T R Hakala; M Jewett; M R Moore; P T Scardino; J M Streitz
Journal:  J Urol       Date:  1980-10       Impact factor: 7.450

10.  Human chorionic gonadotropin (HCG) and alpha-fetoprotein (AFP) in sera and tumor cells of patients with testicular seminoma: a prospective study.

Authors:  N Javadpour; K R McIntire; T A Waldmann
Journal:  Cancer       Date:  1978-12       Impact factor: 6.860

View more
  7 in total

1.  Hyperplasia and hypertrophy of Leydig cells associated with testicular germ cell tumours containing syncytiotrophoblastic giant cells.

Authors:  U U Zimmerli; C E Hedinger
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

2.  Syncytiotrophoblastic giant cells in teratocarcinoma-like tumors derived from Parp-disrupted mouse embryonic stem cells.

Authors:  T Nozaki; M Masutani; M Watanabe; T Ochiya; F Hasegawa; H Nakagama; H Suzuki; T Sugimura
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

3.  HLA-antigen distribution in seminoma, HCG-positive seminoma and non-seminomatous tumours of the testis.

Authors:  C Kratzik; P Aiginger; R Kuzmits; J Spona; M Kirnbauer; A Seiser; W R Mayr
Journal:  Urol Res       Date:  1989

4.  Epidermal growth factor receptor is a marker for syncytiotrophoblastic cells in testicular germ cell tumors.

Authors:  Lukas Hechelhammer; Stephan Störkel; Bernhard Odermatt; Philipp U Heitz; Wolfram Jochum
Journal:  Virchows Arch       Date:  2003-06-03       Impact factor: 4.064

5.  Intermediate filaments and desmosomal plaque proteins in testicular seminomas and non-seminomatous germ cell tumours as revealed by immunohistochemistry.

Authors:  H Denk; R Moll; W Weybora; E Lackinger; F Vennigerholz; A Beham; W W Franke
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1987

6.  DNA hypomethylation and aberrant expression of the human endogenous retrovirus ERVWE1/syncytin-1 in seminomas.

Authors:  Martina Benešová; Kateřina Trejbalová; Denisa Kovářová; Zdenka Vernerová; Tomáš Hron; Dana Kučerová; Jiří Hejnar
Journal:  Retrovirology       Date:  2017-03-17       Impact factor: 4.602

7.  The hot-spot p53R172H mutant promotes formation of giant spermatogonia triggered by DNA damage.

Authors:  Y Xue; A Raharja; W Sim; E S M Wong; S A B Rahmat; D P Lane
Journal:  Oncogene       Date:  2016-11-21       Impact factor: 9.867

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.